Literature DB >> 24840972

Mitotoxicity in distal symmetrical sensory peripheral neuropathies.

Gary J Bennett1, Timothy Doyle2, Daniela Salvemini2.   

Abstract

Chronic distal symmetrical sensory peripheral neuropathy is a common neurological complication of cancer chemotherapy, HIV treatment and diabetes. Although aetiology-specific differences in presentation are evident, the clinical signs and symptoms of these neuropathies are clearly similar. Data from animal models of neuropathic pain suggest that the similarities have a common cause: mitochondrial dysfunction in primary afferent sensory neurons. Mitochondrial dysfunction is caused by mitotoxic effects of cancer chemotherapeutic drugs of several chemical classes, HIV-associated viral proteins, and nucleoside reverse transcriptase inhibitor treatment, as well as the (possibly both direct and indirect) effects of excess glucose. The mitochondrial injury results in a chronic neuronal energy deficit, which gives rise to spontaneous nerve impulses and a compartmental neuronal degeneration that is first apparent in the terminal receptor arbor--that is, intraepidermal nerve fibres--of cutaneous afferent neurons. Preliminary data suggest that drugs that prevent mitochondrial injury or improve mitochondrial function could be useful in the treatment of these conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24840972      PMCID: PMC4870000          DOI: 10.1038/nrneurol.2014.77

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  93 in total

Review 1.  Neurotoxicity of human immunodeficiency virus-1: viral proteins and axonal transport.

Authors:  Italo Mocchetti; Alessia Bachis; Valeriya Avdoshina
Journal:  Neurotox Res       Date:  2011-09-27       Impact factor: 3.911

2.  Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.

Authors:  Jessica A Boyette-Davis; Juan P Cata; Haijun Zhang; Larry C Driver; Gwen Wendelschafer-Crabb; William R Kennedy; Patrick M Dougherty
Journal:  J Pain       Date:  2011-06-24       Impact factor: 5.820

Review 3.  Diabetic neuropathy: one disease or two?

Authors:  Brian C Callaghan; Junguk Hur; Eva L Feldman
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

Review 4.  Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.

Authors:  Peter R Kamerman; Philippa J Moss; Juliane Weber; Victoria C J Wallace; Andrew S C Rice; Wenlong Huang
Journal:  J Peripher Nerv Syst       Date:  2012-03       Impact factor: 3.494

5.  Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.

Authors:  Joseph E Payne; Céline Bonnefous; Kent T Symons; Phan M Nguyen; Marciano Sablad; Natasha Rozenkrants; Yan Zhang; Li Wang; Nahid Yazdani; Andrew K Shiau; Stewart A Noble; Peter Rix; Tadimeti S Rao; Christian A Hassig; Nicholas D Smith
Journal:  J Med Chem       Date:  2010-11-11       Impact factor: 7.446

6.  Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine.

Authors:  Giulia Bianchi; Giordano Vitali; Augusto Caraceni; Sabrina Ravaglia; Giuseppe Capri; Sante Cundari; Claudio Zanna; Luca Gianni
Journal:  Eur J Cancer       Date:  2005-08       Impact factor: 9.162

7.  Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels.

Authors:  Richard G Webster; Keith L Brain; Richard H Wilson; Jean L Grem; Angela Vincent
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 8.  Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

Authors:  William I Sivitz; Mark A Yorek
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

9.  Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-targeted antioxidant on the neuropathies.

Authors:  Satoshi Toyama; Naohito Shimoyama; Yasuo Ishida; Takayoshi Koyasu; Hazel H Szeto; Megumi Shimoyama
Journal:  Anesthesiology       Date:  2014-02       Impact factor: 7.892

10.  Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment.

Authors:  Subir K Roy Chowdhury; Elena Zherebitskaya; Darrell R Smith; Eli Akude; Sharmila Chattopadhyay; Corinne G Jolivalt; Nigel A Calcutt; Paul Fernyhough
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461

View more
  72 in total

1.  HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.

Authors:  Karen Krukowski; Jiacheng Ma; Olga Golonzhka; Geoffroy O Laumet; Tanuja Gutti; John H van Duzer; Ralph Mazitschek; Matthew B Jarpe; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

2.  50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.

Authors:  Nicholas D F Russell; Mark E Cooper
Journal:  Diabetologia       Date:  2015-04-24       Impact factor: 10.122

Review 3.  HIV-1 infection alters energy metabolism in the brain: Contributions to HIV-associated neurocognitive disorders.

Authors:  Bianca Cotto; Kalimuthusamy Natarajanseenivasan; Dianne Langford
Journal:  Prog Neurobiol       Date:  2019-05-18       Impact factor: 11.685

4.  Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats.

Authors:  Mohamad-Reza Aghanoori; Darrell R Smith; Subir Roy Chowdhury; Mohammad Golam Sabbir; Nigel A Calcutt; Paul Fernyhough
Journal:  Exp Neurol       Date:  2017-08-10       Impact factor: 5.330

5.  Paclitaxel-induced increase in mitochondrial volume mediates dysregulation of intracellular Ca2+ in putative nociceptive glabrous skin neurons from the rat.

Authors:  Eser Yilmaz; Simon C Watkins; Michael S Gold
Journal:  Cell Calcium       Date:  2017-01-16       Impact factor: 6.817

6.  Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity.

Authors:  Erin D Wenzel; Alessia Bachis; Valeria Avdoshina; Francesca Taraballi; Ennio Tasciotti; Italo Mocchetti
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-27       Impact factor: 4.147

7.  Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.

Authors:  Aparna Areti; Prashanth Komirishetty; Anil Kumar Kalvala; Karthika Nellaiappan; Ashutosh Kumar
Journal:  Mol Neurobiol       Date:  2018-02-09       Impact factor: 5.590

8.  Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy.

Authors:  Nigel A Calcutt; Darrell R Smith; Katie Frizzi; Mohammad Golam Sabbir; Subir K Roy Chowdhury; Teresa Mixcoatl-Zecuatl; Ali Saleh; Nabeel Muttalib; Randy Van der Ploeg; Joseline Ochoa; Allison Gopaul; Lori Tessler; Jürgen Wess; Corinne G Jolivalt; Paul Fernyhough
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

9.  Cisplatin Toxicity in Dorsal Root Ganglion Neurons Is Relieved by Meclizine via Diminution of Mitochondrial Compromise and Improved Clearance of DNA Damage.

Authors:  Murat F Gorgun; Ming Zhuo; Ella W Englander
Journal:  Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.590

10.  Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain.

Authors:  Salim Megat; Pradipta R Ray; Jamie K Moy; Tzu-Fang Lou; Paulino Barragán-Iglesias; Yan Li; Grishma Pradhan; Andi Wanghzou; Ayesha Ahmad; Michael D Burton; Robert Y North; Patrick M Dougherty; Arkady Khoutorsky; Nahum Sonenberg; Kevin R Webster; Gregory Dussor; Zachary T Campbell; Theodore J Price
Journal:  J Neurosci       Date:  2018-11-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.